Considerations And Implications Of The Proposed Temporary Waiver Of COVID-19 Vaccine-Related Intellectual Property Rights
The Biden administration has indicated support for the temporary waiver of patent protections related to COVID-19 vaccine development.
In the United States, there are three COVID-19 vaccines that received emergency use authorization from the U.S. Food and Drug Administration. Millions of Americans are receiving vaccine dosages daily to inch the country closer toward herd immunity. Mass vaccination and achieving herd immunity would limit the ability of the virus to spread and develop further mutations that […]